Biotech Outperforms Broader Market

The S&P biotech index is up 13% so far this year. Richard Pops, Alkermes chairman & CEO, offers insight on what's behind the biotech surge.

CNBC | February 14, 2012

Tags:. .biotech. .broader. .outperforms. .surge. .ceo